Comprehensive multi-omics analysis of resectable locally advanced gastric cancer: Assessing response to neoadjuvant camrelizumab and chemotherapy in a single-center, open-label, single-arm phase II trial.
Zhao Y, Li D, Zhuang J, Li Z, Xia Q, Li Z, Yu J, Wang J, Zhang Y, Li K, Xu S, Li S, Ma P, Cao Y, Liu C, Xu C, Liu Z, Wei J, Zhang C, Qiao L, Gao X, Hou Z, Liu C, Zheng R, Wang D, Liu Y.
Zhao Y, et al. Among authors: xia q.
Clin Transl Med. 2024 May;14(5):e1674. doi: 10.1002/ctm2.1674.
Clin Transl Med. 2024.
PMID: 38685486
Free PMC article.
Clinical Trial.